"The emulation framework lends the design and conduct of observational analyses some of the rigor required for the planning of a randomized trial. In doing so, it provides an innovative and principled approach to improve the evidence base on the comparative effectiveness of interventions," writes Boris Gershman, MD, and Aaron Fleishman, MPH.
Dr Gershman summarizes recent imaging advances and remaining unmet needs for patients with prostate cancer, and envisions how the use of artificial intelligence may impact the field in the future.
A practical approach to how urologists might best communicate with radiologists and other clinicians regarding mpMRI results for patients with prostate cancer, with an emphasis on optimizing patient care.
An overview of the steps involved in the clinical application of mpMRI imaging, from image generation to results interpretation and follow-up.
Dr Gershman discusses how prostate imaging has improved over time, and how and when clinicians implement mpMRI in their practice.
Expert urologist Boris Gershman, MD shares his approach to prostate cancer diagnosis, staging, and risk stratification, highlighting the increasing use of advanced imaging modalities in recent years.
